Delivery Order SPE2DB20D1100-SPE2DB25FD9G7
- Not listed
- The Defense Logistics Agency awarded a $301 delivery order to Amerisourcebergen Drug Corporation for Lantus insulin vials. As the prime contractor, Amerisourcebergen will supply 10mL vials of the 100 unit/mL formulation of Lantus insulin to fulfill requirements under the agency's pharmaceutical products contract vehicle. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on July 3, 2023. The firm fixed price contract has...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus 100 unit/mL vial (10 mL). The $1,060.42 contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 1 million units of Lantus SoloStar 100 Unit/ML 3ML insulin at a ceiling value of $1,429.34. The order, which is non-set-aside and competitively awarded, is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,187.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $934.70 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 unit/mL vials of Lantus insulin. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 2nd to August 3rd, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency Troop Support Medical awarded a $1,550.68 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units per milliliter Lantus insulin vials in 10 milliliter quantities. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 25 and August 28, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this requirement by the Defense Logistics Agency, which manages the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,150.86 to Amerisourcebergen Drug Corp for the supply of 100 unit/ml vials of Lantus insulin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by August 10, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $99,000 to provide Lantus 100 unit/ml vials. The single day order is for 10ml vials of the insulin drug to be delivered to a facility in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this requirement from its corporate headquarters using its extensive distribution...
- AmerisourceBergen Drug Corp has been awarded a firm fixed-price delivery order valued at $1,278.50 by the Defense Logistics Agency (DLA) for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The award, issued on August 8, 2025, represents a competitive procurement with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9G7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lantus 100 Unit/mL vials (10mL) with a ceiling value of $1,626.00. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and has an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime contract vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support program for military healthcare systems. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, providing a wide range of medications and medical supplies to the Department of Defense, Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major for-profit pharmaceutical distributor headquartered in Pennsylvania, the company has demonstrated capability to meet federal procurement requirements through multiple competitively awarded contracts covering diverse therapeutic domains. The Lantus insulin supply order represents routine pharmaceutical procurement in support of military healthcare operations and diabetes treatment programs across the federal medical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/7/25 |